Expanded Hemodialysis Therapy Market

Expanded Hemodialysis Therapy Market Segmentation by Product (Machines, Dialyzers, Concentrates, Dialysates, and Catheters); by Modality (Short Daily, Conventional Long-Term, and Nocturnal); by End User (Hospital, Independent Dialysis, and Home Dialysis) – Global Demand Analysis & Opportunity Outlook 2030

Buy Now
Report ID: 3372 | Published On: Apr 05, 2022

Preview Analysis

Request Insights
Inflation and Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022. Purchasing power in the country is expected to fell nearly by 2.5%.
On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.


In The News

  • August 31, 2020: Baxter announced that the U.S. Food and Drug Administration (FDA) granted the De Novo authorization for Thernova dialyzers, which are offer expanded hemodialysis therapy to patients with kidney failure.  

Global Expanded Hemodialysis Therapy Market Highlights 2022 – 2030

The global expanded hemodialysis therapy market is estimated to garner a large revenue by recording a CAGR of ~6% over the forecast period, i.e., 2022 – 2030. The growth of the market can be attributed to the increasing prevalence of hypertension and diabetes, growing number of patients of end-stage renal disease (ESRD), and rising technological advancements associated with developing innovative therapies. According to the International Diabetes Foundation, in 2020, about 463 million adults aged between 20 to 79 years were living with diabetes, the population of which is calculated to rise up to 700 million by 2045. Along with these, escalating number of dialysis centers and rise in preference for expanded hemodialysis therapy among patients are also projected to drive market growth in the near future. Furthermore, growing shortage of organ donors and emerging markets in developing regions are expected to offer ample growth opportunities to the market in the upcoming years. 

Global-Expanded-Hemodialysis-Therapy-Market-Overview

 

Get more information on this reportDownload Sample PDF

The market is segmented by modality into short daily, conventional long-term, and nocturnal, out of which, the conventional long-term segment is anticipated to hold the largest share in the global expanded hemodialysis therapy market on account of the high acceptance of expanded hemodialysis therapy among patients suffering from chronic kidney disease and ESRD. In addition, growing focus of prominent manufacturers on developing advanced dialysis equipment is also predicted to boost the growth of the market segment by the end of 2030. Moreover, on the basis of end user, the segment for independent dialysis is projected to occupy the largest share over the forecast period owing to the growing number of dialysis centers across the globe and rising availability of skilled healthcare professionals in dialysis centers.


Major Macro-Economic Indicators Impacting the Market Growth

Global-Healthcare-Expenditure-per-Capita

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.


Global Expanded Hemodialysis Therapy Market Regional Synopsis

On the basis of geographical analysis, the global expanded hemodialysis therapy market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. The market in the Asia Pacific is estimated to witness noteworthy growth over the forecast period on the back of rising per capita income, increasing government initiatives supporting the usage of advanced medical therapies and significant improvements in healthcare infrastructure. Apart from these, growing geriatric population is also assessed to drive market growth in the region. Additionally, the market in North America is projected to grab the largest market share during the forecast period owing to the high healthcare spending, increasing occurrence of chronic kidney diseases and strong presence of market players in the region. As per the United States Centers for Disease Control and Prevention, more than 1 in 7, that is 37 million people or 15 percent of the country’s total population is estimated to have chronic kidney disease.

The global expanded hemodialysis therapy market is further classified on the basis of region as follows

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis


Global-Expanded-Hemodialysis-Therapy-Market-Overview
Get more information on this report: Request Sample PDF

Market Segmentation

Our in-depth analysis of the global expanded hemodialysis therapy market includes the following segments:

By Product

  • Machines
  • Dialyzers
  • Concentrates
  • Dialysates
  • Catheters

By Modality

  • Short Daily
  • Conventional Long-Term
  • Nocturnal

By End User

  • Hospital
  • Independent Dialysis
  • Home Dialysis

Growth Drivers

  • Growing Prevalence of Diabetes and Hypertension
  • Increasing Technological Advancements to Develop Innovative Therapies

Challenges

  • Complications and Risks Associated with Dialysis


Global-Healthcare-Expenditure-per-Capita
Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the Market

    • B. Braun Melsungen AG
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Asahi Kasei Corporation
    • Baxter International, Inc.
    • Fresenius Medical Care AG & Co. KGaA
    • Nikkiso Co., Ltd.
    • Nipro Corporation
    • NxStage Medical, Inc.
    • Cantel Medical Corp.
    • Satellite Healthcare, Inc.
    • MEDIVATORS, Inc.

     


Key Questions Answered in the Report

1) What are the major factors driving the growth of the expanded hemodialysis therapy market?

Ans: The major growth drivers for the market are growing prevalence of diabetes and hypertension and increasing technological advancements to develop innovative therapies.

2) What would be the CAGR of expanded hemodialysis therapy market over the forecast period?

Ans: The market is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2022 – 2030.

3) What are the challenges affecting the expanded hemodialysis therapy market growth?

Ans: Complications and risks associated with dialysis is estimated to hamper the market growth.

4) Which region will provide more business opportunities for growth of expanded hemodialysis therapy market in future?

Ans: Asia Pacific will provide more business opportunities for market growth owing to the rising per capita income and significant improvements in healthcare infrastructure in the region.

5) Who are the major players dominating the expanded hemodialysis therapy market?

Ans: The major players in the market are B. Braun Melsungen AG, Asahi Kasei Corporation, Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co., Ltd., and others.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the expanded hemodialysis therapy market?

Ans: The market is segmented by product, modality, end user, and by region.

8) Which segment captures the largest market size in the end user segment in the expanded hemodialysis therapy market?

Ans: The independent dialysis segment is anticipated to hold largest market size and is estimated to grow at a notable CAGR over the forecast period and display significant growth opportunities.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Submit RFP    Buy Now Download Research Report Sample